These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 21104146)
1. IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls. Xu B; Niu XB; Wang ZD; Cheng W; Tong N; Mi YY; Min ZC; Tao J; Li PC; Zhang W; Wu HF; Zhang ZD; Wang ZJ; Hua LX; Feng NH; Wang XR Mol Biol Rep; 2011 Apr; 38(4):2589-96. PubMed ID: 21104146 [TBL] [Abstract][Full Text] [Related]
2. Association of Duan HX; Chen YY; Shi JZ; Ren NN; Li XJ Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135142 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 -174G/C polymorphism and the risk of Alzheimer's disease in Caucasians: a meta-analysis. Han XM; Wang CH; Sima X; Liu SY Neurosci Lett; 2011 Oct; 504(1):4-8. PubMed ID: 21767605 [TBL] [Abstract][Full Text] [Related]
4. Association of Interleukin-6-174G/C Polymorphism With Ischemic Stroke: An Updated Meta-Analysis. Chai J; Cao XL; Lu F Front Neurol; 2021; 12():799022. PubMed ID: 35069427 [No Abstract] [Full Text] [Related]
5. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis. An PP; Feng LN; Zhang XX; Jin QL Medicine (Baltimore); 2020 Dec; 99(50):e23659. PubMed ID: 33327352 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 gene -174G>C polymorphism and chronic obstructive pulmonary disease risk: a meta-analysis. Xie XM; Ke R; Zhang YH; Wang GZ; Zhu YT; Hussian T; Yang L; Li MX Genet Mol Res; 2015 Jul; 14(3):8516-25. PubMed ID: 26345781 [TBL] [Abstract][Full Text] [Related]
7. A meta-analysis on correlation between interleukin-6 -174G/C polymorphism and end-stage renal disease. Feng Y; Tang Y; Zhou H; Xie K Ren Fail; 2017 Nov; 39(1):350-356. PubMed ID: 28164733 [TBL] [Abstract][Full Text] [Related]
8. Association of Interleukin-6 -174G/C Polymorphism with the Risk of Diabetic Nephropathy in Type 2 Diabetes: A Meta-analysis. Cui ZH; Lu XT; Xiao KL; Chen Y; Li HQ Curr Med Sci; 2019 Apr; 39(2):250-258. PubMed ID: 31016518 [TBL] [Abstract][Full Text] [Related]
9. Association between interleukin-6 -174G/C polymorphism and the risk of Alzheimer's disease: a meta-analysis. Hua Y; Guo X; Huang Q; Kong Y; Lu X Int J Neurosci; 2013 Sep; 123(9):626-35. PubMed ID: 23510010 [TBL] [Abstract][Full Text] [Related]
10. Association between Rezaei F; Mohammadi H; Heydari M; Sadeghi M; Mozaffari HR; Khavid A; Godiny M; Brand S; M Dürsteler K; Beatrix Brühl A; Cordier D; Sadeghi-Bahmani D Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33922260 [TBL] [Abstract][Full Text] [Related]
11. Lack of association between IL-6 -174G>C polymorphism and lung cancer: a meta-analysis. Liu Y; Song XL; Zhang GL; Peng AM; Fu PF; Li P; Tan M; Li X; Li M; Wang CH Genet Mol Res; 2015 Jan; 14(1):163-9. PubMed ID: 25729947 [TBL] [Abstract][Full Text] [Related]
12. Association of IL-6 -174 G>C Polymorphism with Susceptibility to Colorectal Cancer and Gastric Cancer: a Systematic Review and Meta-Analysis. Jafari-Nedooshan J; Dastgheib SA; Kargar S; Zare M; Raee-Ezzabadi A; Heiranizadeh N; Sadeghizadeh-Yazdi J; Neamatzadeh H Acta Medica (Hradec Kralove); 2019; 62(4):137-146. PubMed ID: 32036845 [TBL] [Abstract][Full Text] [Related]
13. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects. Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of IL-6 -174G/C polymorphism and psoriasis risk. Nie G; Xie CL; Cao YJ; Xu MM; Shi X; Zou AL; Qi JH Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421005 [TBL] [Abstract][Full Text] [Related]
15. Association between rs20417 polymorphism in cyclooxygenase-2 and gastric cancer susceptibility: Evidence from15 case-control studies. Chen S; Chen L; Tan Y; Wang J Medicine (Baltimore); 2019 May; 98(18):e15468. PubMed ID: 31045826 [TBL] [Abstract][Full Text] [Related]
16. Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis. Zhang K; Zhang L; Zhou J; Hao Z; Fan S; Yang C; Liang C Onco Targets Ther; 2016; 9():567-77. PubMed ID: 26869801 [TBL] [Abstract][Full Text] [Related]
17. A comprehensive meta-analysis comprising 149 case-control studies to investigate the association between IL-6 gene rs1800795 polymorphism and multiple disease risk. Harun-Or-Roshid M; Mollah MNH; Jesmin Gene; 2023 Apr; 861():147234. PubMed ID: 36736866 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the Correlation Between Interleukin-6 Promoter Polymorphism -174G/C and Interferon Regulatory Factor 4 rs12203592 Polymorphism With Skin Cancer Susceptibility. Wu M; Cao Y; Liu YL; Ma LL; Yang XH Am J Ther; 2016; 23(6):e1758-e1767. PubMed ID: 26928068 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer. Zhai K; Yang Y; Gao ZG; Ding J Oncotarget; 2017 Jul; 8(27):44490-44497. PubMed ID: 28548958 [TBL] [Abstract][Full Text] [Related]
20. A meta-analysis on associations of IL-6 and IL-10 polymorphisms with susceptibility to ischemic stroke. Chen M; Yang Y J Neuroimmunol; 2019 Oct; 335():577004. PubMed ID: 31446341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]